Search clinical trials for: Telmisartan (Micardis®) vs. Placebo

Total 2250 results

McMaster University
Canadian Institutes of Health Research (CIHR); Boehringer Ingelheim; Medtronic; Heart and Stroke Foundation of Canada

Completed

Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

Metabolic Syndrome X

Canada
Boehringer Ingelheim

Completed

Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension

Hypertension
Emory University
National Institute on Aging (NIA)

Completed

Health Evaluation in African Americans Using RAS Therapy (HEART)

Alzheimer's Disease

United States
Boehringer Ingelheim

Completed

Micardis® in Patients With Essential Hypertension

Hypertension
Coordinación de Investigación en Salud, Mexico

Completed

Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients

Inflammation | End-stage Renal Disease

Mexico
Boehringer Ingelheim

Completed

A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II)

Hypertension
Boehringer Ingelheim

Completed

Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH) (ARAMIS)

Hypertension
Boehringer Ingelheim

Completed

The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects

Obesity | Insulin Resistance

Italy, United States, Canada, Germany, Denmark
Boehringer Ingelheim

Completed

Micardis®. Observational Study in Patients With Essential Hypertension

Hypertension
University of Hawaii
Queens Medical Center

Terminated

INvestigating TELmisartin Study (INTEL)

Covid19

United States
Boehringer Ingelheim

Completed

A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

Hypertension
Boehringer Ingelheim

Completed

A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® / LORZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM) (TOPAS)

Hypertension
Boehringer Ingelheim

Completed

Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure

Hypertension
Boehringer Ingelheim

Completed

Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension

Hypertension
Boehringer Ingelheim

Completed

Pharmacovigilance and Patient Compliance in Hypertensive Patients

Hypertension
Boehringer Ingelheim

Completed

Study to Assess Potential Different Properties of Telmisartan Compared to Candesartan in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension

Hypertension
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan/g Ramipril Fixed Dose Combination Compared With the Monocomponents Telmisartan and Ramipril (Two Different Formulations) Given Concomitantly to Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Bioequivalence of Telmisartan / Ramipril Fixed Dose Combination Compared With the Monocomponents Given Concomitantly to Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Safety, Tolerability and Efficacy of Micardis® in Patients With Essential Hypertension

Hypertension
Kyoto Prefectural University of Medicine

Terminated

Effects of Telmisartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients (KCPS)

Myocardial Ischemia | Hypertension | Angina Pectoris | Acute Coronary Syndrome | Acute Myocardial Infarction

Japan
Boehringer Ingelheim

Completed

Evolution of Pulse Pressure Following Initiation of Antihypertensive Therapy in Patients With Essential Arterial Hypertension

Hypertension
Boehringer Ingelheim

Completed

Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus

Hypertension
Xiaoduo Fan

Terminated

Telmisartan Pilot Study on Treatment Resistant Schizophrenia

Schizophrenia | Schizo Affective Disorder | Treatment-resistant Schizophrenia

United States
Boehringer Ingelheim

Completed

Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

Hypertension
Boehringer Ingelheim

Completed

Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure

Hypertension
Boehringer Ingelheim

Completed

Observation of Therapy With Micardis® (Telmisartan) in Patients With Essential Hypertension in Hospitals

Hypertension
Becton, Dickinson and Company

Completed

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Diabetes

United States
Boehringer Ingelheim

Completed

Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo)

Hypertension
Chong Kun Dang Pharmaceutical
Asan Medical Center

Completed

CKD-828 Drug Interaction Study (Telmisartan)

Healthy Male Volunteers

Korea, Republic of
Boehringer Ingelheim

Completed

Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers

Healthy
Boehringer Ingelheim

Completed

Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers

Healthy
Yuhan Corporation
Linical Korea

Terminated

A Clinical Trial of YMC017 in Hypertensive and Hypercholesterolemic Patients With Metabolic Syndrome

Metabolic Syndrome

Korea, Republic of
University of California, Los Angeles
The Campbell Foundation

Completed

A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease

Endothelial Dysfunction

United States
University of California, Los Angeles
California HIV/AIDS Research Program

Completed

HIV and Fat Accumulation (MATH)

HIV Infection

United States
Boehringer Ingelheim

Completed

Investigating the Effect of Telmisartan (Micardis®) on the Average 24h Blood Pressure of Therapy-naive and Therapy-experienced Patients

Hypertension
Hackensack Meridian Health

Terminated

Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation

GVHD

United States
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan; Teleflex

Completed

Venous Injection Compared To intraOsseous Injection During Resuscitation of Patients With Out-of-hospital Cardiac Arrest (VICTOR)

Vascular Access | Out-of-Hospital Cardiac Arrest | Intraosseous Access | Emergency Medical Service | Intravenous Access

Taiwan
Charite University, Berlin, Germany
German Federal Ministry of Education and Research

Terminated

Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation (MACPAF)

Symptomatic Paroxysmal Atrial Fibrillation

Germany
Seung-Jung Park
CardioVascular Research Foundation, Korea

Withdrawn

Star-Close Versus Angio-Seal for Femoral Artery Hemostasis (CLOSE)

Percutaneous Intervention Via Femoral Artery

Korea, Republic of
Navy General Hospital, Beijing
First People's Hospital of Foshan; General Hospital of Armed Police, Beijing; PLA General Hospital, Beijing

Unknown

Intracoronary or Intravenous Infusion Human Wharton' Jelly-derived Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (WJ-ICMP Tria)

Ischemic Cardiomyopathy
HK inno.N Corporation

Recruiting

A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers

Hypertension

Korea, Republic of
Boehringer Ingelheim

Withdrawn

Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic Practice

Hypertension

Japan
Northwestern University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease (TELEX)

Peripheral Artery Disease

United States
Tyler J Curiel

Not yet recruiting

Telmisartan in Prostate Cancer

Prostate Cancer

United States
Pharmtechnology LLC
Algorithme Pharma, An Altasciences Company

Completed

Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

Bioequivalence

Canada
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

A Double Blind Clinical Trial of DCS for Food Anxiety

Anorexia and Bulimia Nervosa

United States
Pfizer

Completed

Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements

Healthy

United States
Boehringer Ingelheim
Bayer; GlaxoSmithKline

Completed

PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes

Stroke

United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, El Salvador, Finland, France, Germany, Greece, Hong Kong, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, No... and more
Boehringer Ingelheim

Completed

Validation of Predictors of OAC Initiation Using EMR Data

Atrial Fibrillation

United States

3

Subscribe